Article
Overview of the Essential Tremor
Neuropsychiatric Disease and Treatment
(2010)
Abstract
Essential tremor (ET) is one of the most common movement disorders in the world. Despite this, only one medication (propranolol) is approved by the Food and Drug Administration (FDA) to treat it. Fortunately, recent studies have identified some additional medications as treatment of ET. Surgical procedures, such as deep brain stimulation of the ventral intermediate nucleus of the thalamus, offer treatment for refractory tremor. The epidemiology, pathogenesis, and medical and surgical treatment of ET will be discussed in this paper.
Keywords
- Essential tremor,
- Diagnosis,
- Treatment,
- Pathogenesis
Disciplines
Publication Date
July 7, 2010
DOI
10.2147/NDT.S4795
Publisher Statement
This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/us/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at http://www.dovepress.com/permissions.php. Article obtained from Neuropsychiatric Disease and Treatment.
Citation Information
Theresa A. Zesiewicz, Abinaya Chari, Israt Jahan, Amber M. Miller, et al.. "Overview of the Essential Tremor" Neuropsychiatric Disease and Treatment Vol. 6 Iss. 1 (2010) p. 401 - 408 ISSN: 1178-2021 Available at: http://works.bepress.com/kelly_sullivan/21/